187 related articles for article (PubMed ID: 20160040)
41. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
[TBL] [Abstract][Full Text] [Related]
42. Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation.
Chen W; Zou P; Zhao Z; Weng Q; Chen X; Ying S; Ye Q; Wang Z; Ji J; Liang G
Oncotarget; 2016 Mar; 7(13):16593-609. PubMed ID: 26919094
[TBL] [Abstract][Full Text] [Related]
43. Induction of cell membrane protrusions by the N-terminal glutaredoxin domain of a rare splice variant of human thioredoxin reductase 1.
Dammeyer P; Damdimopoulos AE; Nordman T; Jiménez A; Miranda-Vizuete A; Arnér ES
J Biol Chem; 2008 Feb; 283(5):2814-21. PubMed ID: 18042542
[TBL] [Abstract][Full Text] [Related]
44. Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341).
Kamer S; Ren Q; Dicker AP
Arch Gynecol Obstet; 2009 Jan; 279(1):41-6. PubMed ID: 18461345
[TBL] [Abstract][Full Text] [Related]
45. Homozygous mutation in TXNRD1 is associated with genetic generalized epilepsy.
Kudin AP; Baron G; Zsurka G; Hampel KG; Elger CE; Grote A; Weber Y; Lerche H; Thiele H; Nürnberg P; Schulz H; Ruppert AK; Sander T; Cheng Q; Arnér ES; Schomburg L; Seeher S; Fradejas-Villar N; Schweizer U; Kunz WS
Free Radic Biol Med; 2017 May; 106():270-277. PubMed ID: 28232204
[TBL] [Abstract][Full Text] [Related]
46. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462
[TBL] [Abstract][Full Text] [Related]
47. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity.
Fang J; Lu J; Holmgren A
J Biol Chem; 2005 Jul; 280(26):25284-90. PubMed ID: 15879598
[TBL] [Abstract][Full Text] [Related]
48. Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity.
Zheng X; Ma W; Sun R; Yin H; Lin F; Liu Y; Xu W; Zeng H
Redox Biol; 2018 Apr; 14():237-249. PubMed ID: 28965082
[TBL] [Abstract][Full Text] [Related]
49. Curcumin targeting the thioredoxin system elevates oxidative stress in HeLa cells.
Cai W; Zhang B; Duan D; Wu J; Fang J
Toxicol Appl Pharmacol; 2012 Aug; 262(3):341-8. PubMed ID: 22634334
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of thioredoxin reductase 1 correlates with platinum-based chemotherapeutic induced tissue injury.
Cheng P; Liu H; Li Y; Pi P; Jiang Y; Zang S; Li X; Fu A; Ren X; Xu J; Holmgren A; Lu J
Biochem Pharmacol; 2020 May; 175():113873. PubMed ID: 32092292
[TBL] [Abstract][Full Text] [Related]
51. Dual targeting of EGFR and focal adhesion kinase in 3D grown HNSCC cell cultures.
Eke I; Cordes N
Radiother Oncol; 2011 Jun; 99(3):279-86. PubMed ID: 21704406
[TBL] [Abstract][Full Text] [Related]
52. Curcumin: a potential radio-enhancer in head and neck cancer.
Khafif A; Lev-Ari S; Vexler A; Barnea I; Starr A; Karaush V; Haif S; Ben-Yosef R
Laryngoscope; 2009 Oct; 119(10):2019-26. PubMed ID: 19655336
[TBL] [Abstract][Full Text] [Related]
53. Curcumin as therapeutics for the treatment of head and neck squamous cell carcinoma by activating SIRT1.
Hu A; Huang JJ; Li RL; Lu ZY; Duan JL; Xu WH; Chen XP; Fan JP
Sci Rep; 2015 Aug; 5():13429. PubMed ID: 26299580
[TBL] [Abstract][Full Text] [Related]
54. Curcumin analog EF24 induces apoptosis and downregulates the mitogen activated protein kinase/extracellular signal-regulated signaling pathway in oral squamous cell carcinoma.
Lin C; Tu C; Ma Y; Ye P; Shao X; Yang Z; Fang Y
Mol Med Rep; 2017 Oct; 16(4):4927-4933. PubMed ID: 28791378
[TBL] [Abstract][Full Text] [Related]
55. Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway.
Dai XF; Ding J; Zhang RG; Ren JH; Ma CM; Wu G
Int J Radiat Biol; 2013 Sep; 89(9):724-31. PubMed ID: 23682582
[TBL] [Abstract][Full Text] [Related]
56. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells.
Zou P; Xia Y; Chen W; Chen X; Ying S; Feng Z; Chen T; Ye Q; Wang Z; Qiu C; Yang S; Liang G
Oncotarget; 2016 Apr; 7(14):18050-64. PubMed ID: 26919110
[TBL] [Abstract][Full Text] [Related]
57. Curcuminoid WZ35 synergize with cisplatin by inducing ROS production and inhibiting TrxR1 activity in gastric cancer cells.
He W; Xia Y; Cao P; Hong L; Zhang T; Shen X; Zheng P; Shen H; Liang G; Zou P
J Exp Clin Cancer Res; 2019 May; 38(1):207. PubMed ID: 31113439
[TBL] [Abstract][Full Text] [Related]
58. Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways.
Sivanantham B; Sethuraman S; Krishnan UM
ACS Comb Sci; 2016 Jan; 18(1):22-35. PubMed ID: 26505786
[TBL] [Abstract][Full Text] [Related]
59. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
[TBL] [Abstract][Full Text] [Related]
60. Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.
Schütze C; Dörfler A; Eicheler W; Zips D; Hering S; Solca F; Baumann M; Krause M
Strahlenther Onkol; 2007 May; 183(5):256-64. PubMed ID: 17497097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
